Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10637/10595
Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.contributor.otherUCH. Departamento de Medicina y Cirugía Animal-
dc.creatorVilar, José M.-
dc.creatorDamiá Giménez, Elena-
dc.creatorRubio Zaragoza, Mónica.-
dc.creatorSantana, Angelo-
dc.creatorSopena Juncosa, Joaquín Jesús.-
dc.creatorCerón Madrigal, José Joaquín-
dc.creatorTvarijonaviciute, Asta-
dc.creatorCugat Bertomeu, Ramón-
dc.creatorCarrillo Poveda, José María.-
dc.date2017-
dc.date.accessioned2019-09-25T04:00:28Z-
dc.date.available2019-09-25T04:00:28Z-
dc.date.issued2017-01-25-
dc.identifier.citationVilar, JM., Damiá, E., Rubio, M., Santana, A., Sopena, J., Ceron, J. (2017). Therapeutic doses of plasma rich in growth factors cannot provoke cancer by means of the IGF-1 pathway or inflammation in dogs. Journal of Applied Animal Research, vol. 45, n. 1, pp. 490-493. DOI: https://doi.org/10.1080/09712119.2016.1218888-
dc.identifier.issn0971-2119-
dc.identifier.issn0974-1844 (Electrónico)-
dc.identifier.urihttp://hdl.handle.net/10637/10595-
dc.descriptionEste artículo se encuentra disponible en la siguiente URL: https://www.tandfonline.com/doi/full/10.1080/09712119.2016.1218888-
dc.description.abstractA potential relationship between an increased risk of cancer and increased levels of serum insulin-like growth factor-1 (IGF-1), and presence of cancer and high levels of C-reactive protein (CRP) has been previously reported. This study evaluated the influence of a single intramuscular injection of plasma rich in growth factors (PRGF) on serum concentrations of IGF-1 and CRP in dogs. Two groups of eight healthy beagles were injected with two different doses of PRGF in lumbar muscles. For each treatment, IGF-1 and CRP were analysed from blood samples obtained at baseline and the following three days post injection. No differences were found when IGF-1 and CRP were compared among times in the two protocols. Local application of PRGF at clinical doses did not cause significant changes in systemic concentrations of IGF-1 or detectable inflammation.-
dc.formatapplication/pdf-
dc.language.isoes-
dc.language.isoen-
dc.publisherInforma UK.-
dc.relation.ispartofJournal of Applied Animal Research, vol. 45, n. 1 (2017).-
dc.rightshttp://creativecommons.org/licenses/by/4.0/deed.es-
dc.subjectCrecimiento - Factores - Uso terapéutico.-
dc.subjectGrowth factors - Therapeutic use.-
dc.subjectCancer in dogs - Risk factors.-
dc.subjectPlasma sanguíneo - Uso terapéutico.-
dc.subjectCáncer en los perros - Factores de riesgo.-
dc.subjectBlood plasma - Therapeutic use.-
dc.titleTherapeutic doses of plasma rich in growth factors cannot provoke cancer by means of the IGF-1 pathway or inflammation in dogs-
dc.typeArtículo-
dc.identifier.doihttps://doi.org/10.1080/09712119.2016.1218888-
dc.centroUniversidad Cardenal Herrera-CEU-
Aparece en las colecciones: Dpto. Medicina y Cirugía Animal




Los ítems de DSpace están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.